Roche has put together a cancer immunotherapy research network and committed up to $100 million to support collaborations between the 21 academic centers.

Stallergenes Greer and Stanford University have teamed up to look for biomarkers of peanut oral immunotherapy efficacy.

Bristol-Myers Squibb has teamed with Infinity Pharmaceuticals to add another study to its burgeoning roster of combination trials featuring PD-1 drug Opdivo.

An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft-controversial, hot-tempered and…

An IPO for Ra Pharmaceuticals has priced raising $92 million, while another for Myovant Sciences has commitments from Pfizer and BB Biotech.

A St. Louis, MO-based preclinical startup has nabbed a GSK partnership. The pair will focus on antibiotic-sparing drugs to treat and prevent urinary tract…

Merck is confident that its Keytruda will work well in combination with traditional chemotherapy. Up next are next-gen combos.

NantVentures has made an investment in microcap Australian biotech Benitec Biopharma.